Cooper Financial Group Pfizer Inc Transaction History

Cooper Financial Group

$670 Million
Q2 2024

A detailed history of Cooper Financial Group transactions in Pfizer Inc stock. As of the latest transaction made, Cooper Financial Group holds 18,917 shares of PFE stock, worth $505,462. This represents 0.08% of its overall portfolio holdings.

Number of Shares

18,917

Previous 9,086 108.2%

Holding current value

$505,462

Previous $252,000 109.92%

% of portfolio

0.08%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	BUY	$25.26 - $29.6 $248,331 - $290,997	9,831 Added 108.2%	18,917 $529,000
Q1 2024 Apr 11, 2024	SELL	$25.89 - $29.73 $4,815 - $5,529	-186 Reduced 2.01%	9,086 $252,000
Q4 2023 Jan 16, 2024	BUY	$26.13 - $33.94 $1,515 - $1,968	58 Added 0.63%	9,272 $266,000
Q3 2023 Oct 13, 2023	SELL	$32.09 - $37.51 $289,355 - $338,227	-9,017 Reduced 49.46%	9,214 $305,000
Q2 2023 Jul 07, 2023	SELL	$36.12 - $41.79 $242,076 - $280,076	-6,702 Reduced 26.88%	18,231 $668,000
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $234,646 - $305,474	5,957 Added 31.39%	24,933 $1.02 Million
Q4 2022 Jan 13, 2023	BUY	$41.75 - $54.5 $26,427 - $34,498	633 Added 3.45%	18,976 $0
Q3 2022 Oct 13, 2022	BUY	$43.76 - $53.42 $28,312 - $34,562	647 Added 3.66%	18,343 $803,000
Q2 2022 Jul 11, 2022	BUY	$46.53 - $55.17 $90,175 - $106,919	1,938 Added 12.3%	17,696 $928,000
Q1 2022 Apr 12, 2022	BUY	$45.75 - $56.69 $272,624 - $337,815	5,959 Added 60.81%	15,758 $816,000
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $141,314 - $209,475	-3,420 Reduced 25.87%	9,799 $579,000
Q3 2021 Oct 06, 2021	BUY	$39.25 - $50.42 $6,280 - $8,067	160 Added 1.23%	13,219 $569,000
Q2 2021 Jul 12, 2021	SELL	$35.91 - $40.68 $1,975 - $2,237	-55 Reduced 0.42%	13,059 $511,000
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $153,082 - $172,646	-4,571 Reduced 25.85%	13,114 $475,000
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $195,832 - $249,018	5,851 Added 49.44%	17,685 $651,000
Q3 2020 Oct 09, 2020	BUY	$31.75 - $37.25 $14,636 - $17,172	461 Added 4.05%	11,834 $434,000
Q2 2020 Jul 15, 2020	BUY	$30.12 - $36.54 $79,125 - $95,990	2,627 Added 30.04%	11,373 $372,000
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $81,468 - $116,400	3,014 Added 52.58%	8,746 $285,000
Q4 2019 Jan 07, 2020	SELL	$32.92 - $37.36 $25,578 - $29,028	-777 Reduced 11.94%	5,732 $225,000
Q3 2019 Oct 08, 2019	SELL	$32.49 - $42.13 $180,416 - $233,947	-5,553 Reduced 46.04%	6,509 $234,000
Q2 2019 Jul 08, 2019	BUY	$36.98 - $41.52 $40,197 - $45,132	1,087 Added 9.9%	12,062 $523,000
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $37,650 - $41,364	-1,004 Reduced 8.38%	10,975 $466,000
Q4 2018 Jan 17, 2019	BUY	$38.47 - $43.86 $460,832 - $525,398	11,979 New	11,979 $523,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cooper Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Cooper Financial Group with notifications on news.

Account

Cooper Financial Group Pfizer Inc Transaction History